Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$22.16 USD
+0.18 (0.82%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $22.16 0.00 (0.00%) 5:00 PM ET
2-Buy of 5 2
A Value C Growth F Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
FMS 22.16 +0.18(0.82%)
Will FMS be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for FMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FMS
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?
FMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View
Other News for FMS
Fresenius Medical price target raised to EUR 41 from EUR 39 at Barclays
Fresenius Medical price target raised by EUR 2 at Barclays
Fresenius Medical’s Novalung ECMO System selected by Premier
Fresenius Medical's Novalung ECMO System selected by Premier
Global companies with at least 50% U.S. revenue exposure as Trump eyes tariffs: BofA